Volume 19, issue 1, December 2021
106 articles in this issue
-
-
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications
Authors (first, second and last of 10)
-
Incidence and characteristics of arterial thromboemboli in patients with COVID-19
Authors (first, second and last of 7)
-
A catastrophic seronegative anti-phospholipid syndrome: case and literature review
Authors (first, second and last of 9)
-
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: a systematic review and metanalysis
Authors (first, second and last of 6)
-
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review
Authors (first, second and last of 16)
-
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: a longitudinal cohort study
Authors (first, second and last of 9)
-
Morphologic change in deep venous thrombosis in the lower extremity after therapeutic anticoagulation
Authors (first, second and last of 6)
-
The impact on renal function after long-term use of anticoagulants in atrial fibrillation patients
Authors (first, second and last of 10)
-
Clopidogrel versus ticagrelor in the treatment of Chinese patients undergoing percutaneous coronary intervention: effects on platelet function assessed by platelet function tests and mean platelet volume
Authors (first, second and last of 9)
-
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia
Authors (first, second and last of 6)
-
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer
Authors (first, second and last of 6)
-
The disulfide bond Cys2724-Cys2774 in the C-terminal cystine knot domain of von Willebrand factor is critical for its dimerization and secretion
Authors (first, second and last of 8)
-
-
Deep venous thrombosis in an individual with statin-exposed anti-SRP myopathy: case report and review of literature
Authors (first, second and last of 6)
-
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
Authors (first, second and last of 4)
-
Association of circulating proprotein convertase subtilisin/kexin type 9 concentration, prothrombin time and cardiovascular outcomes: a prospective cohort study
Authors (first, second and last of 10)
-
Impact of oral anticoagulation therapy on postoperative atrial fibrillation outcomes: a systematic review and meta-analysis
Authors (first, second and last of 7)
-
Cardiovascular risk factors are associated with augmented thrombogenicity in healthy individuals: analysis using the Total Thrombus-formation Analysis System
Authors (first, second and last of 10)
-
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
Authors (first, second and last of 6)
-
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials
Authors (first, second and last of 4)
-
Prognostic value of characteristics of plaque combined with residual syntax score among patients with STEMI undergoing primary PCI: an intravascular optical coherence tomography study
Authors (first, second and last of 12)
-
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation
Authors (first, second and last of 5)
-
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study
Authors (first, second and last of 4)
-
Monitoring coagulation-fibrinolysis activation prompted timely diagnosis of hemophagocytic lymphohistiocytosis-related disseminated intravascular coagulation
Authors (first, second and last of 5)
-
Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study
Authors (first, second and last of 5)
-
Anticoagulation may contribute to antimicrobial treatment of Lemierre syndrome: a case report
Authors (first, second and last of 5)
-
Low FXIII activity levels in intensive care unit hospitalized COVID-19 patients
Authors (first, second and last of 15)
-
Fibrinolytic markers could be useful predictors of severity in patients with pulmonary arterial hypertension: a retrospective study
Authors (first, second and last of 9)
-
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study
Authors (first, second and last of 10)
This is part of 1 collection:
-
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines
Authors (first, second and last of 9)
-
COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab
Authors (first, second and last of 4)
-
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism
Authors (first, second and last of 14)
-
An optimal window of platelet reactivity by LTA assay for patients undergoing percutaneous coronary intervention
Authors (first, second and last of 15)
-
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article
Authors (first, second and last of 4)
-
Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome
Authors (first, second and last of 5)
-
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery
Authors (first, second and last of 7)
-
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis
Authors (first, second and last of 6)
-
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
Authors (first, second and last of 4)
-
-
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia
Authors (first, second and last of 4)
-
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand
Authors (first, second and last of 5)
-
A thrombophilia family with protein S deficiency due to protein translation disorders caused by a Leu607Ser heterozygous mutation in PROS1
Authors (first, second and last of 13)
-
Point-of-care detection and differentiation of anticoagulant therapy - development of thromboelastometry-guided decision-making support algorithms
Authors (first, second and last of 7)
-
-
Dimethyl fumarate inhibits antibody-induced platelet destruction in immune thrombocytopenia mouse
Authors (first, second and last of 15)
-
Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
Authors (first, second and last of 6)
-
Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity
Authors (first, second and last of 5)
-
Association between cardiovascular risk-factors and venous thromboembolism in a large longitudinal study of French women
Authors (first, second and last of 6)
-
Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19
Authors (first, second and last of 4)
